-Henlius y Dr. Reddy’s firman un acuerdo de licencia para la expansión de HLX15 (biosimilar de daratumumab en investigación) en Europa y EE.UU. SHANGHAI, 7 de febrero de 2025 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK) anunció hoy que ha firmado un acuerdo de licencia con Dr….
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.